CAST RNA-Guided DNA Integration System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current CRISPR-associated transposons (CASTs) are rare and limited in their understanding, particularly regarding their prevalence, diversity in self-targeting strategies, and molecular mechanisms, which hinders their application in gene editing.

Innovation Solution

Development of a system for RNA-guided DNA integration using isolated I-F and I-B CRISPR-Associated Transposons (CASTs) comprising specific protein components such as TnsA-TnsB-TnsC and TniQ-Cas8-Cas5-Cas7-Cas6, which enable targeted DNA integration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If CRISPR-associated transposons are used for gene editing, then targeted DNA integration capability is improved, but the rarity and limited understanding of CAST systems hinders their application

Engineering Contradiction:
Improvetargeted DNA integration capabilityVSAvoidsystem complexity due to rarity and limited understanding
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent segments the CAST system into distinct functional modules: the TnsABC transposase complex for DNA integration, the TniQ-Cas8-Cas5-Cas7-Cas6 complex for RNA-guided target recognition, and the crRNA for sequence specificity. This modular segmentation allows each component to be independently characterized, expressed, and optimized, reducing the overall complexity of working with CAST systems despite their rarity.

Inventive Principle:
Principle #1Segmentation

2Device complexity

If TnsD and TnsE are dispensed with in Class 1 CASTs, then the system simplification is achieved, but the target selection mechanism becomes less understood

Engineering Contradiction:
Improvesystem simplification by removing TnsD and TnsEVSAvoidloss of target selection mechanism understanding
Core Design Contradiction:
Device complexityVSLoss of information

Solution Approach 1:

The patent introduces the TniQ-Cas8-Cas5-Cas7-Cas6 complex as an intermediary that bridges the simplified CAST system (without TnsD/TnsE) and the target DNA selection process. This intermediary complex, guided by crRNA, performs the target selection function that would otherwise be performed by TnsD and TnsE, maintaining target selection capability while achieving system simplification.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Device complexity

If minimal CRISPR array with few spacers is used, then the system size is reduced, but the ability to target other mobile genetic elements for horizontal gene transfer is limited

Engineering Contradiction:
Improvesystem size reduction with minimal CRISPR arrayVSAvoidability to target diverse mobile genetic elements
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The patent demonstrates that the TniQ-Cas8-Cas5-Cas7-Cas6 complex functions as a universal target recognition module that can work with different crRNA sequences to target various mobile genetic elements. The minimal CRISPR array configuration provides a compact, versatile system where the same core machinery can be redirected to different targets by simply changing the crRNA guide sequence, achieving both size reduction and maintained adaptability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system achieves efficient RNA-guided DNA integration, expanding the capabilities for gene editing and providing insights into the evolution and mechanisms of CASTs.

Implementation Method 1

a crRNA-guided TniQ-Cascade effector complex

Methodology Applied
Scientific EffectRNA-guided DNA binding:

Data Source

PatentUS20250066819A1Crispr-associated transposons and uses thereof
Publication Date: 2025.02.27 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US20250066819A1 patent drawing
  • US20250066819A1 patent drawing
  • US20250066819A1 patent drawing

AI summary

Disclosed herein are CRISPR-associated transposons (CASTs), which co-opt Cas genes for RNA-guided transposition. Disclosed herein are new families of CASTs, including a non-Tn7 CAST. These CASTs are useful in a variety of gene editing applications, so also disclosed herein are methods of using the CASTs.